New Research – Global Biosimilar Market Analysis, Share, Regional Outlook 2017 – Acute Market Reports

Scope of the Report

The report titled “Global Biosimilar Market: Trends & Opportunities (2015 Edition)” analyzes the global biologics market, with exhaustive discussion on demand of Biosimilars with increase in patent expiry of innovator drugs. The key market challenges recognized by the analysts and the major trends biosimilar market are presented in the report. Further, key manufacturers of Biosimilars like Sandoz, Teva, Hospira and Dr. Reddy’s Lab are profiled in the report.

Browse Full Report Visit – http://www.acutemarketreports.com/report/global-biosimilar-market-trends-and-opportunities-2015-edition

Product Coverage

  • Recombinant Glycosylated Biosimilars (EPO,mAb,Follitropin)
  • Humira, Enbrel, Remicade, Herceptin
  • Recombinant Non-Glycosylated Biosimilars (Insulin,G-csf,Interferons,hGh)
  • Company Coverage
  • Sandoz(Novartis)
  • Hospira
  • Teva
  • Dr. Reddy’s Lab

Executive Summary

Rising budgetary pressures to reduce healthcare expenditures, patent expiries of blockbuster drugs, growing demand for cost-effective alternatives, increasing aging population, conductive government initiatives and rising incidences of various diseases are significant factors that are responsible for the growth of global biosimilar market (2013 to 2018). On the other hand stringent regulatory environment in some countries, high manufacturing complexities, costs, and presence of low priced generic drugs and high-entry barriers are considered to hinder the market growth. Emerging pharmaceutical market and less stringent government regulatory frameworks in few countries can provides some of the major opportunities for biosimilars market. In addition, increased collaboration between manufacturing companies and outsourcing of biosimilar products are key trends for biosimilars market.

The biosimilar products market is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides. Globally there are 280 biosimilars in pipeline and their clinical trials are increasing at a rate of 20% annually.

Browse All Reports of This Category – http://www.acutemarketreports.com/category/biotechnology-market

  1. EXECUTIVE SUMMARY
  2. GLOBAL BIOSIMILAR MARKET

2.1 Overview of Biosimilar Market

2.1.1 History

2.1.2 Prescription of Biosimilars

2.1.3 Naming of Biosimilars

2.1.4 Determination of Biosimilarity

2.1.5 Differences between Biosimilar and Original Drugs

2.1.6 Manufacture of Biosimilars

2.1.7 Safety, Efficacy, Quality

2.1.8 Variability in Biosimilars

  1. GLOBAL BIOSIMILAR MARKET: SIZING AND GROWTH

3.1 Biosimilar Market Size: 2009-2013

3.2 Forecasted Biosimilar market Size : 2014-2018

  1. BIOSIMILAR MARKET ANALYSIS: BY GEOGRAPHY

4.1 Asia-Pacific

4.1.1 China

4.1.2 India

4.1.3 South Korea, Taiwan, ASEAN

4.1.4 Latin America

4.1.5 Brazil

4.1.6 Mexico

4.1.7 Argentina

  1. BIOSIMILAR MARKET: PRODUCT ANALYSIS

5.1 Recombinant Glycosylated Biosimilars

5.1.1 Market Size: 2009-2013

5.1.2 Forecasted: 2014-218

5.1.2.1 Original epoetin (EPO) products

5.1.2.2 Original follitropin product

5.1.2.3 Original Monoclonal antibodies

  1. MARKET DYNAMICS OF BIOSIMILAR MARKET

6.1 Growth drivers

6.1.1 Patent expiry

6.1.2 Increase in Demand of Biologics

6.1.3 Increase demand to lower the soaring health costs

6.1.4 Focus On Therapeutic Research Areas (Diabetes, Cancer) including Monoclonal Antibody and Human Insulin

6.1.5 Increase in expenditure on biologics globally

6.2 Market Challenges

6.2.1 Efficacy issues

About – Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.

Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.

Contact Us :

Name : Chris Paul

ACUTE MARKET REPORTS

Designation : Global Sales Manager

Toll Free(US/CANADA): +1-855-455-8662

Email : sales@acutemarketreports.com

Website :http://www.acutemarketreports.com

Designed by CyFocus.com
Powered by CyFocus.net